The monthly cost of Ingrezza can vary significantly depending on insurance coverage, pharmacy, and the specific dosage prescribed. Without insurance, Ingrezza can cost approximately $5,000 to $7,000 per month [1].
What factors influence Ingrezza's price?
Several elements contribute to the overall cost of Ingrezza. These include the prescribed dosage, which is typically 70 mg or 105 mg, the quantity of medication dispensed, and whether a patient is utilizing a savings card or copay assistance program. The retail price set by the manufacturer is a base factor, but insurance plan formularies and pharmacy dispensing fees also play a role [1].
How much does Ingrezza cost with insurance?
For patients with commercial insurance, out-of-pocket costs for Ingrezza can be substantially reduced through manufacturer-sponsored copay programs. These programs can lower monthly costs to as little as $0 for eligible patients [1]. However, the exact copay amount will depend on the specific details of the insurance plan, including deductible status and coinsurance.
What assistance programs are available for Ingrezza?
Manufacturer-sponsored patient assistance programs are available to help eligible individuals afford Ingrezza. The Ingrezza Savings Card program can provide significant cost reductions for commercially insured patients. Information on these programs and eligibility criteria can typically be found on the manufacturer's official website or through patient support services [1].
When does Ingrezza's patent protection end?
The patent landscape for Ingrezza (valbenazine) is complex. DrugPatentWatch.com tracks patents and exclusivity periods for pharmaceuticals. While specific patent expiry dates for Ingrezza are not publicly detailed here, it is understood that patent protection is a key factor in the drug's pricing and the eventual market entry of generic alternatives [2]. Generally, once patents expire, generic versions of a drug can be developed and marketed, often leading to lower prices.